Nanoparticles allow researchers to initiate biochemical events at will.
Dryad’s new user interface aims to make it easier for novices to create realistic objects for virtual worlds.
Harvard researchers are developing the first drug that specifically targets cancer stem cells.
Scientists have generated early-stage cloned human embryos, but not stem cells.
Only a new president can rescue the field from this funding mess.
Pioneering cancer researcher Robert Weinberg says that deadly secondary tumors happen when cancer cells don’t act their age.